(Q47895673)

6 February 2018

title

Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology (English)

1 reference

6 February 2018

author name string

Tree JA

1

1 reference

6 February 2018

Williams A

2

1 reference

6 February 2018

Clark S

3

1 reference

6 February 2018

Hall G

4

1 reference

6 February 2018

Marsh PD

5

1 reference

6 February 2018

Ivanyi J

6

1 reference

6 February 2018

publication date

1 December 2004

1 reference

6 February 2018

Clinical and Experimental Immunology

published in

1 reference

6 February 2018

volume

138

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

405-409

1 reference

6 February 2018

Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

A mobile form of the Henderson apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL/6 and BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Cellular immune responses to four doses of percutaneous bacille Calmette-Guérin in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Enhanced antimycobacterial response to recombinant Mycobacterium bovis BCG expressing latency-associated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Improved tuberculosis DNA vaccines by formulation in cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues. Role of adjuvants and routes of immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02648.X

Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809232

Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809232

Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809232

The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809232

Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809232

The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809232

Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice

26 August 2018

1 reference

12 December 2020

Intranasal vaccination of mice against infection with Mycobacterium tuberculosis

1 reference

12 December 2020

Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs

1 reference

12 December 2020

Dysregulated response to mycobacterial cord factor trehalose-6,6'-dimycolate in CD1D-/- mice

1 reference

12 December 2020

A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice

1 reference

12 December 2020

10.1111/J.1365-2249.2004.02648.X

Identifiers

DOI

1 reference

6 February 2018

PMC publication ID

1809232

0 references

1 reference

6 February 2018